Federal regulators and several states have sued the World Professional Association for Transgender Health, alleging its guidelines pushed medical transition for minors despite limited evidence and conflicts of interest. The complaint claims WPATH framed its Standards of Care as evidence-based while internal documents and expert remarks showed uncertainty and research gaps. That legal fight could reshape how doctors, insurers, and families approach puberty blockers, hormones, and surgeries for young people.
The lawsuit was filed in federal court in Texas by the Federal Trade Commission alongside the attorneys general of Alaska, Iowa, Nebraska and Texas. It accuses WPATH of promoting guidance that clinicians leaned on when recommending puberty blockers, cross-sex hormones and irreversible surgeries for minors. At stake is whether those recommendations were presented honestly to families when risks and benefits were uncertain.
FTC Chairman Andrew Ferguson put the case in plain terms, saying, “Children, but especially their parents, must have complete and truthful information when making decisions to purchase medical services.” He added, “For decades, the FTC has taken action against entities that make deceptive and unsubstantiated health-related claims.” That consumer-protection framing makes clear the agency sees this as more than a policy dispute.
WASHINGTON POST ADMITS SCIENCE BEHIND PUBERTY BLOCKERS AND HORMONES FOR MINORS NOT CLEAR
The complaint cites internal memos and interviews where WPATH contributors warned about shaky evidence. The document references a 2023 strategy memo from Standards of Care 8th edition lead author Dr. Eli Coleman stating that “all of us are painfully aware that there are many gaps in research to back up our recommendations.” Dr. Amy Tishelman, lead author on the children chapter, also admitted there was no established “research basis” for deciding the best assessments or treatments for “transgender youth.”
Federal regulators say WPATH removed age minimums from its Standards of Care for certain procedures in 2022 without a solid scientific rationale. Internal discussions, the complaint alleges, show leaders struggled to point to evidence supporting those changes. That fuels the charge that the organization elevated ideology and practice preferences over rigorous science.
ESSAY EXPOSES CRUMBLING MEDICAL CONSENSUS ON YOUTH GENDER SURGERY
Critics also highlight conflicts of interest among contributors who, regulators say, had financial or professional stakes tied to the very treatments being recommended. Kurt Miceli of Do No Harm called out those ties and argued they skewed guidance toward promoting pediatric medical transition. “The conflicts of interest that are within the standards of care are significant, and again, not brought to light, and this is part of that deception, and the concern that WPATH has sort of stated that the science is there behind pediatric medical transition when it is not,” he said.
PLASTIC SURGEON CITES ‘EMOTIONAL BLACKMAIL,’ POOR EVIDENCE IN WARNING AGAINST YOUTH GENDER SURGERIES
The complaint alleges WPATH characterized interventions as “lifesaving” despite weak evidence on suicide reduction. It recounts instances where parents were allegedly asked whether they would “rather have a live daughter or a dead son” when weighing treatment options. Miceli described this rhetoric as medically unsupported and harmful, saying, “When WPATH says that these are life-saving interventions, and then we hear physicians tell parents, ‘Would you rather have a dead son or a living daughter?’, and we hear that line repeated, which again is not supported by evidence by any means whatsoever.”
“What WPATH did was stack the deck with folks who had a financial invested interest in promoting pediatric medical transition, and subsequently you get guidelines that push hormones, puberty blockers, and surgeries,” Miceli said. He added bluntly, “The benefits that WPATH is claiming are there actually aren’t. In fact, the benefits are a very low certainty.” Those are the arguments driving calls for broader review.
WPATH rejected the lawsuit as politically motivated and legally flawed. “This is the second time this year the Trump Administration has abused the authority of its agencies to interfere with Americans’ rights to seek and obtain the healthcare that should be decided between a patient and their physician,” the organization said in a statement. It also insisted, “For more than 50 years, WPATH has been committed to developing guidelines informed by established scientific standards, expert consensus, and patient centered values.”
Republican officials behind the suit argue the issue demands immediate scrutiny from major medical groups that relied on WPATH’s guidance. “We need the American Medical Association, the Endocrine Society, the American Academy of Pediatrics, the American Psychiatric Association—the list goes on—we need them to look at the evidence as well, and they need to do that immediately,” Miceli said. He summed up the complaint’s urgency with a final charge: “The standards of care is terribly flawed, and again it has done considerable harm as a result.”
Darnell Thompkins is a conservative opinion writer from Atlanta, GA, known for his insightful commentary on politics, culture, and community issues. With a passion for championing traditional values and personal responsibility, Darnell brings a thoughtful Southern perspective to the national conversation. His writing aims to inspire meaningful dialogue and advocate for policies that strengthen families and empower individuals.